Stroke study seeks to personalize statin therapy

NCT ID NCT07344610

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study is observing 800 people who recently had an ischemic stroke or have significant artery narrowing. All are taking high doses of statins (atorvastatin or rosuvastatin) for at least a week. Researchers want to see how much their cholesterol drops and what factors influence that drop, to help guide future personalized treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

atorvastatin or rosuvastatin

What this could lead to

If successful, this could help doctors tailor statin doses to individual patients after a stroke, potentially improving prevention of future strokes.

What could go wrong

This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may vary widely among patients and may not apply to all stroke types.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atherosclerosis ischemic stroke

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Lu Wang

    RECRUITING

    Shenyang, Liaoning, 110840, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••